Granulocyte colony-stimulating factor use during first urse chemotherapy for non-Hodgkin's lymphoma: National SEER-medicare study.

被引：0
|
作者：
Chrischilles, EA
Rubenstein, LM
Voelker, MD
Wright, KB
Link, BK
Brooks, JM
Delgado, DJ
机构：
[1] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA
[4] Amgen Inc, Thousand Oaks, CA USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1817
引用
收藏
页码：499A / 499A
页数：1
相关论文
共 50 条
  • [1] Time to first neutropenia hospitalization during first course chemotherapy among newly diagnosed non-Hodgkin's lymphoma patients: National SEER-medicare study.
    Voelker, MD
    Rubenstein, LM
    Chrischilles, EA
    Chen-Hardee, SS
    Link, BK
    Wright, KB
    Brooks, JM
    Delgado, DJ
    BLOOD, 2003, 102 (11) : 253A - 253A
  • [2] Factors associated with first course chemotherapy among older patients with newly diagnosed non-Hodgkin's lymphoma: National SEER-Medicare study.
    Voelker, MD
    Chrischilles, EA
    Wright, KB
    Link, BK
    Park, TR
    Delgado, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 548S - 548S
  • [3] Neutropenia-related inpatient medicare costs during first course chemotherapy among newly diagnosed non-Hodgkin's lymphoma patients: National SEER-Medicare study.
    Brooks, JM
    Voelker, MD
    Chen-Hardee, SS
    Park, TR
    Wright, KB
    Link, BK
    Chrischilles, EA
    Rubenstein, LM
    Delgado, DJ
    BLOOD, 2003, 102 (11) : 498A - 498A
  • [4] Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma
    N Yokose
    K Ogata
    H Tamura
    E An
    K Nakamura
    K Kamikubo
    S Kudoh
    K Dan
    T Nomura
    British Journal of Cancer, 1998, 77 : 2286 - 2290
  • [5] Economic evaluation of prophylactic granulocyte colony-stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma
    Doorduijn, JK
    Buijt, I
    van der Holt, B
    van Agthoven, M
    Sonneveld, P
    Groot, CAU
    HAEMATOLOGICA, 2004, 89 (09) : 1109 - 1117
  • [6] Chemotherapy and granulocyte-colony stimulating factor for non-Hodgkin's lymphoma of the head and neck
    Tsuge, I
    Suzuki, K
    Moribe, K
    Motai, H
    Kimura, T
    Umeda, K
    Kobayashi, T
    Yokota, A
    Hondo, J
    Baba, S
    ACTA OTO-LARYNGOLOGICA, 1996, : 129 - 134
  • [7] Use of Granulocyte Colony-Stimulating Factor and Neutropenic Events among Breast Cancer and Non-Hodgkin's Lymphoma Patients
    Lin, Wan-Ting
    Wen, Tsun-Jen
    Chiang, Shao-Chin
    Shen, Li-Jiuan
    Hsiao, Fei-Yuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 243 - 244
  • [8] Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma
    Hasegawa, Y
    Ninomiya, H
    Kamoshita, M
    Ohtani, K
    Kobayashi, T
    Kojima, H
    Nagasawa, T
    Abe, T
    INTERNAL MEDICINE, 1997, 36 (05) : 360 - 364
  • [9] Patterns of Granulocyte Colony-Stimulating Factor (G-CSF) Use in Elderly Patients with Non-Hodgkin's Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy
    Page, John H.
    Solid, Craig
    Chia, Victoria M.
    Blaes, Anne Hudson
    Barron, Richard L.
    Choi, Mi Rim
    Arneson, Thomas J.
    BLOOD, 2012, 120 (21)
  • [10] Cost-minimization analysis of prophylactic granulocyte colony-stimulating factor after induction chemotherapy in children with non-Hodgkin's lymphoma
    Rubino, C
    Laplanche, A
    Patte, C
    Michon, J
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (10): : 750 - 755
12345